Tyra Biosciences, Inc. (TYRA) has 5 SEC Form 4 insider filings on record in the last 90 days. That includes 1 insider purchase totalling $20K. Most recent filing: Sept. 17, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 17, 2026 filed Sept. 15, 2026 | Rueb Yuliya Vice President, Finance (PAO) | $26,702 | 2,925 | +35% | No | |
|
|
||||||
| Sept. 17, 2026 filed Sept. 15, 2026 | Harris Todd President and CEO | $7,887 | 864 | +0% | No | |
|
|
||||||
| Sept. 17, 2026 filed Sept. 15, 2026 | Fuhrman Alan Chief Financial Officer | $8,682 | 951 | +3% | No | |
|
|
||||||
| Sept. 17, 2026 filed Sept. 15, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | $199,990,915 | 9,078,529 | 0% | No | |
|
|
||||||
| Sept. 11, 2026 filed Sept. 9, 2026 | Verjee Rehan Director | +$20,000 | 972 | New | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free